Hepatitis Delta The Hidden Epidemic

(54:15)

ECHO 2023 Session 24: Hepatitis Delta Epidemiology, Virology, and Treatment Landscape

(31:16)

Hepatitis Delta 101 Train-the-Trainer Presentation

(27:27)

Hepatitis Delta: The Case for Double Reflex Testing for All Individuals Living with Hepatitis B

(50:40)

European Profile of Hepatitis Delta and Bulevirtide

(1:1:5)

ECHO 2022 Session 14: Hepatitis Delta

(23:20)

Hepatitis Delta Virus: Overview and Latest Treatments

(1:5:30)

Hepatitis Delta Rare Disease Day

(1:22)

Diagnosing Hepatitis Delta in the U.S.

(1:1:58)

Hepatitis Delta - Disease mechanism

(5:26)

Hepatitis Delta: Current \u0026 Future Treatments

(1:13:27)

The International Profile of Hepatitis Delta

(57:43)

Hepatitis Delta Virus: Screening Barriers Around the World \u0026 Management in the Absence of Treatment

(1:5:7)

Hepatitis Delta: The Hidden Epidemic

(54:15)

Hepatitis Delta Treatment Endpoints: How Do We Measure Success in the Era of Emerging Therapies

(1:1:1econd)

Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus Webinar

(48:10)

Modeling the immune reaction to Hepatitis Delta infection

(50:19)

EASL Policy Dialogue — World Hepatitis Day - Spotlight on Hepatitis D — Season 2, Episode 4

(8:37)

Hepatitis Delta: what are the new developments, what are the challenges? | Cihan Yurdaydin, MD

(24:38)